Key Procedure Data by Predicted Risk Groups
CABG
AVR
MVR
CABG
+AVR
CABG
+MVR
PreOp Length of Stay
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Length of Stay
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
Total Length of Stay
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
Number of Distal Anastamosis
U.S.
Canada
U.S.
Canada
U.S.
Canada
Cross Clamp Time
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
Perfusion Time
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
ReOperation for Bleeding
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Deep Sternal Infection
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Permanent Stroke
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Ventilation > 1 Day
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Dialysis Dependent Renal Failure
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Atrial Fibrilation
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp At Least One Complication
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp At Least One Major Complication
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Pacing From O.R.
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Inotrope Use From O.R.
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp AntiArrythmics Use From O.R.
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Blood Product Use
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
PostOp Multi System Failure
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
U.S.
Canada
CABG
AVR
MVR
CABG
+AVR
CABG
+MVR